Robert Thomas Freeman - 08 Oct 2024 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Reporting relationship: Chief Financial Officer
Issuer ticker: ALHC
Reported as of: 08 Oct 2024
Net transaction value: -$473,350
SEC form: 4
Accepted by SEC: 10 Oct 2024, 18:56:25 UTC
Prior SEC filing: 03 Oct 2024
Next SEC filing: 16 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for Robert Thomas Freeman

Key filing fact

Robert Thomas Freeman filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 10 Oct 2024.

Key facts

This page summarizes Robert Thomas Freeman's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Oct 2024, 18:56.

Change

Previous filing in this sequence was filed on 03 Oct 2024.
Current net transaction value: -$473,350.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALHC transaction

Common Stock

Sale

Transaction value: $473,350
Shares: -39,320
Change %: -17%
Price: $12.04
Shares after: 194,609
Date: 08 Oct 2024
Ownership: See Footnote
Footnotes: F1, F2, F3

ALHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 865,407
Date: 08 Oct 2024
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Date of Rule 10b5-1 plan adoption: 03/15/2024

Footnote F2

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.20. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Footnote F3

Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.